Molecular Mechanism and Rationale
The molecular foundation of microglial replacement centers on astrocyte-mediated disruption of the purinergic signaling network that maintains yolk sac-derived microglial identity. Under homeostatic conditions, resident microglia maintain their ontogenic identity through continuous P2Y12 receptor signaling via extracellular ATP/ADP gradients and fractalkine (CX3CL1) interactions with neurons. However, perinatal immune activation fundamentally alters this paradigm through astrocyte-specific activation of the JAK2-STAT3 pathway. Pattern recognition receptor activation in astrocytes leads to rapid upregulation of ectonucleotidases CD39 and CD73, which systematically degrade the extracellular purine landscape essential for microglial homeostatic signaling.
Curated pathway from expert analysis
flowchart TD
A["Target Gene: CCR2"]
B["Molecular Mechanism<br/>Pathway Activation"]
C["Cellular Phenotype<br/>Neuronal or Glial Response"]
D["Network Effect<br/>Circuit-Level Consequence"]
E["Disease Relevance<br/>Neurodegeneration Link"]
A --> B --> C --> D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style E fill:#1b5e20,stroke:#81c784,color:#81c784No linked papers recorded for this hypothesis yet.
Median TPM across 13 brain regions for P2RY12 from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for P2RY12.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.